Literature DB >> 15453853

Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the regulation of corneal neovascularization and wound healing.

Lisha Gan1, Per Fagerholm, Jan Palmblad.   

Abstract

PURPOSE: To study the change in expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in the rabbit cornea and limbus following a penetrating, central corneal alkali burn. The influence of different cells on VEGF and VEGFR-2 expression was studied by excluding granulocytes from the wound area.
METHODS: Fourteen New Zealand white rabbits were subjected to a penetrating, 5-mm diameter, central corneal alkali burn in one eye under general anaesthesia. Seven of the rabbits were given injections of fucoidin for 36 hours. The rabbits were killed after 36 hours and the corneas were excised with a sclera rim and prepared for immunohistochemistry.
RESULTS: Both VEGF and VEGFR-2 are strongly expressed in the frontline of repopulating epithelial, stromal and endothelial cells during wound healing, irrespective of granulocyte presence. Vascular endothelial cells express VEGF strongly after injury, but only in the presence of granulocytes.
CONCLUSION: Corneal neovascularization requires the presence of granulocytes to stimulate vascular endothelial cells. During wound healing in this area, VEGF is a factor that stimulates proliferation and migration and that is not influenced by granulocytes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15453853     DOI: 10.1111/j.1600-0420.2004.00312.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  36 in total

1.  Pharmacologic uncoupling of angiogenesis and inflammation during initiation of pathological corneal neovascularization.

Authors:  Jeremy M Sivak; Allison C Ostriker; Amber Woolfenden; John Demirs; Rosemarie Cepeda; Debby Long; Karen Anderson; Bruce Jaffee
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

2.  Delayed cutaneous wound healing in aged rats compared to younger ones.

Authors:  Onur C Soybir; Sibel Ö Gürdal; Ebru Ş Oran; Feti Tülübaş; Meral Yüksel; Ayşenur İ Akyıldız; Ayhan Bilir; Gürsel R Soybir
Journal:  Int Wound J       Date:  2011-12-01       Impact factor: 3.315

3.  Curcumin nanoparticles inhibit corneal neovascularization.

Authors:  Nirparaj Pradhan; Rajdeep Guha; Sushovan Chowdhury; Sudip Nandi; Aditya Konar; Sarbani Hazra
Journal:  J Mol Med (Berl)       Date:  2015-04-17       Impact factor: 4.599

4.  Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin).

Authors:  Roberta P A Manzano; Gholam A Peyman; Palwasha Khan; Petros E Carvounis; Muhamet Kivilcim; Min Ren; Jonathan C Lake; Patricia Chévez-Barrios
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

5.  The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization.

Authors:  Banu Torun Acar; Elvin Halili; Suphi Acar
Journal:  Int Ophthalmol       Date:  2013-02-13       Impact factor: 2.031

6.  Storage stability of bevacizumab in polycarbonate and polypropylene syringes.

Authors:  H Khalili; G Sharma; A Froome; P T Khaw; S Brocchini
Journal:  Eye (Lond)       Date:  2015-03-27       Impact factor: 3.775

7.  Screening of antiangiogenic potential of twenty two marine invertebrate extracts of phylum Mollusca from South East Coast of India.

Authors:  Pankaj Gupta; Muthuvel Arumugam; Raj Vardhan Azad; Rohit Saxena; Supriyo Ghose; Nihar Ranjan Biswas; Thirumurthy Velpandian
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

8.  Peroxynitrite upregulates angiogenic factors VEGF-A, BFGF, and HIF-1α in human corneal limbal epithelial cells.

Authors:  Negin Ashki; Ann M Chan; Yu Qin; Wei Wang; Meagan Kiyohara; Lin Lin; Jonathan Braun; Madhuri Wadehra; Lynn K Gordon
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

9.  Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Authors:  Peng Chen; Hongmei Yin; Yao Wang; Jing Mi; Wenxiao He; Lixin Xie; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-02-27       Impact factor: 2.367

10.  Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.

Authors:  Olga Dratviman-Storobinsky; Bat-Chen R Avraham-Lubin; Murat Hasanreisoglu; Nitza Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-11-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.